Protein kinase Cα determines HER2 fate in breast carcinoma cells with HER2 protein overexpression without gene amplificationMAGNIFICO, Alessandra; ALBANO, Luisa; CAMPANER, Stefano et al.Cancer research (Baltimore). 2007, Vol 67, Num 11, pp 5308-5317, issn 0008-5472, 10 p.Article

HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviorsMENARD, Sylvie; BALSARI, Andrea; CASALINI, Patrizia et al.Clinical cancer research. 2002, Vol 8, Num 2, pp 520-525, issn 1078-0432Article

Ascites Regression and Survival Increase in Mice Bearing Advanced-stage Human Ovarian Carcinomas and Repeatedly Treated Intraperitoneally With CpG-ODNDE CESARE, Michelandrea; SFONDRINI, Lucia; PRATESI, Graziella et al.Journal of immunotherapy (1997). 2010, Vol 33, Num 1, pp 8-15, issn 1524-9557, 8 p.Article

Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2GENNARI, Roberto; MENARD, Sylvie; OLIVIERO, Barbara et al.Clinical cancer research. 2004, Vol 10, Num 17, pp 5650-5655, issn 1078-0432, 6 p.Article

Axillary Lymph Node Dissection Versus No Dissection in Patients With T1NO Breast Cancer: A Randomized Clinical Trial (INT09/98)AGRESTI, Roberto; MARTELLI, Gabriele; BIANCHI, Giulia et al.Cancer. 2014, Vol 120, Num 6, pp 885-893, issn 0008-543X, 9 p.Article

Maspin influences response to doxorubicin by changing the tumor microenvironment organizationTRIULZI, Tiziana; RATTI, Manuela; BALSARI, Andrea et al.International journal of cancer (Print). 2014, Vol 134, Num 12, pp 2789-2797, issn 0020-7136, 9 p.Article

Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective studyCAMPIGLIO, Manuela; BUFALINO, Rosaria; BOTTINI, Alberto et al.Breast cancer research and treatment. 2011, Vol 128, Num 1, pp 147-154, issn 0167-6806, 8 p.Article

Influence of Lignans Depletion on Murine Mammary Gland MorphologyROSSINI, Anna; ZANOBBIO, Laura; PALAZZO, Marco et al.Nutrition and cancer. 2010, Vol 62, Num 2, pp 237-242, issn 0163-5581, 6 p.Article

Identification of a novel function for 67-kDa laminin receptor: Increase in laminin degradation rate and release of motility fragmentsARDINI, Elena; SPORCHIA, Barbara; POLLEGIONI, Loredano et al.Cancer research (Baltimore). 2002, Vol 62, Num 5, pp 1321-1325, issn 0008-5472Article

Tumor-Initiating Cells of HER2-Positive Carcinoma Cell Lines Express the Highest Oncoprotein Levels and Are Sensitive toTrastuzumabMAGNIFICO, Alessandra; ALBANO, Luisa; CAMPANER, Stefano et al.Clinical cancer research (Print). 2009, Vol 15, Num 6, pp 2010-2021, issn 1078-0432, 12 p.Article

Influence of antibiotic treatment on breast carcinoma development in proto-neu transgenic miceROSSINI, Anna; RUMIO, Cristiano; SFONDRINI, Lucia et al.Cancer research (Baltimore). 2006, Vol 66, Num 12, pp 6219-6224, issn 0008-5472, 6 p.Article

Expression of protein tyrosine phosphatase alpha (RPTPα) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivoARDINI, Elena; AGRESTI, Roberto; TAGLIABUE, Elda et al.Oncogene (Basingstoke). 2000, Vol 19, Num 43, pp 4979-4987, issn 0950-9232Article

The HER2 World: Better Treatment Selection for Better OutcomeTAGLIABUE, Elda; CAMPIGLIO, Manuela; PUPA, Serenella M et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 82-85, issn 1052-6773, 4 p.Conference Paper

MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancerIORIO, Marilena V; CASALINI, Patrizia; TAGLIABUE, Elda et al.European journal of cancer (1990). 2008, Vol 44, Num 18, pp 2753-2759, issn 0959-8049, 7 p.Article

Linking survival of HER2-positive breast carcinoma patients with surgical invasivenessTAGLIABUE, Elda; AGRESTI, Roberto; CASALINI, Patrizia et al.European journal of cancer (1990). 2006, Vol 42, Num 8, pp 1057-1061, issn 0959-8049, 5 p.Article

microRNA-205 Regulates HER3 in Human Breast CancerLORIO, Marilena V; CASALINI, Patrizia; PIOVAN, Claudia et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 6, pp 2195-2200, issn 0008-5472, 6 p.Article

Two Distinct Local Relapse Subtypes in Invasive Breast Cancer : Effect on their Prognostic ImpactCASALINI, Patrizia; CARCANGIU, Maria Luisa; TAMMI, Raija et al.Clinical cancer research. 2008, Vol 14, Num 1, pp 25-31, issn 1078-0432, 7 p.Article

Salad vegetables dietary pattern protects against HER-2-positive breast cancer : A prospective Italian studySANT, Milena; ALLEMANI, Claudia; BERRINO, Franco et al.International journal of cancer. 2007, Vol 121, Num 4, pp 911-914, issn 0020-7136, 4 p.Article

Anti-tumor activity of CpG-ODN aerosol in mouse lung metastasesSFONDRINI, Lucia; SOMMARIVA, Michele; TAGLIABUE, Elda et al.International journal of cancer (Print). 2013, Vol 133, Num 2, pp 383-393, issn 0020-7136, 11 p.Article

Elements Related to Heterogeneity of Antibody-Dependent Cell Cytotoxicity in Patients Under Trastuzumab Therapy for Primary Operable Breast Cancer Overexpressing Her2VARCHETTA, Stefania; GIBELLI, Nadia; COSTA, Alberto et al.Cancer research (Baltimore). 2007, Vol 67, Num 24, pp 11991-11999, issn 0008-5472, 9 p.Article

Evaluation of arrayed primer extension for TP53 mutation detection in breast and ovarian carcinomasKRINGEN, Pedro; BERGAMASCHI, Anna; UNDLIEN DUE, Eldri et al.BioTechniques. 2005, Vol 39, Num 5, pp 755-761, issn 0736-6205, 7 p.Article